Researcher Stories
Get to know the PhRMA Foundation’s award recipients.
Improving Antibody-Drug Conjugates for Cancer Treatment
Alina Ringaci, a PhD student at Boston University, is studying how to improve antibody-drug conjugates, a type of cancer treatment that delivers drugs directly to cancer cells.
Watch Now
Understanding a Tiny RNA Modification’s Outsized Role in Cancer
Allison Siegenfeld, a postdoctoral trainee at Harvard Medical School, is studying a hallmark of cancer — the dysregulation of messenger RNA levels — to better understand how treatments can target this mechanism of action.
Watch Now
Turning Bad Cholesterol Into a Good Drug Delivery Vehicle
Dr. Lisa Volpatti of Northwestern University is creating a novel drug delivery system that treats inflammation by taking advantage of the body’s natural systems.
Watch NowTracking Residual Cancer Cells After Treatment to Prevent Relapse
Yu-Hsiang Chen, a postdoctoral trainee at the University of Texas MD Anderson Cancer Center, is using single-cell technology to study the cancer cells that remain after stem cell transplant to treat blood cancer.
Awardee Spotlight
Annalisa Ferrotta
- Cornell University
“I am incredibly grateful for the support from the PhRMA Foundation to advance therapeutic development for glioblastoma, a devastating disease with no effective treatment options. In addition to connecting me to a network of renowned scientists, this fellowship empowers my research to push the boundaries of innovation with the ultimate goal of improving patient outcome. ”
Leveraging Real-World Data and Patient Preferences to Improve Depression Treatment
PhD candidate Tim Lai at Auburn University is using real-world data and patient preferences to help guide more effective treatment of depression.